CNWBiotech

News releases from the biotechnology industry, distributed by CNW Group. Contact: CNW Group Ltd.,
88 Queens Quay West, Suite 3000, Toronto, ON M5J 0B8

[CNWBiotech @CNWBiotech]

?? adMare is pleased to announce the launch of the adMare Institute. It will provide data-based insights to the sector and stakeholders across Canada with the aim of advancing #lifesciences and related public policies in Canada https://t.co/xxlrjGVc2g

[CNWBiotech @CNWBiotech]

Minister Sajjan to announce funding to support #BC's biomanufacturing and #aerospace sectors tomorrow. Learn more via @PacifiCanEN: https://t.co/u2BMfeWfrD

[CNWBiotech @CNWBiotech]

@Merck Selects @Perceiv_AI for Inaugural Digital Sciences Studio Cohort https://t.co/RE1FHued3c https://t.co/NO2ag5bELt

[CNWBiotech @CNWBiotech]

Le ministre Vandal annonce un investissement de 2,5 millions de dollars de @PrairiesCanFR pour la sécurité alimentaire mondiale avec @globalfoodsecur en #Sask

#FinancéparPrairiesCan https://t.co/q1qv16adBQ

[CNWBiotech @CNWBiotech]

Minister Vandal announces a $2.5 million @PrairiesCanEN investment for global food security with @globalfoodsecur in #Sask

#PrairiesCanFunded https://t.co/OkRehHegs4 https://t.co/WTny6QttIH

[CNWBiotech @CNWBiotech]

.@PharmAlaBiotech & SABI Mind Announce MDMA Supply Agreement https://t.co/ICR57S3kOp

[CNWBiotech @CNWBiotech]

@PharmAlaBiotech has signed an agreement to expand their GMP MDMA distribution and testing by partnering with CCrest Labs, a montreal-based cGMP testing facility with a Health Canada Controlled Substances Dealer's License https://t.co/qWXcAX9dtZ

[CNWBiotech @CNWBiotech]

.@PharmAlaBiotech will be supplying clincial-grade MDMA to @MindMedicineAU for their trials later this year, a first-of-its-kind partnership in the #Psychedelics industry. https://t.co/CNpy9ptwea https://t.co/0ppgmYW7p3

[CNWBiotech @CNWBiotech]

Dolphin Vagus Nerve Stim Receives Health Canada Approval for Treatment of Covid-19 Respiratory Distress Syndrome (ARDS) #DolphinMPS https://t.co/48OAJQYNAY

[CNWBiotech @CNWBiotech]

.@Abbamedix_corp Launches Strain Developed for #Veterans with #PTSD @CanadaHouse #cannabis https://t.co/udUbIQDee2

[CNWBiotech @CNWBiotech]

BetterLife Pharma Enters into a Licensing Agreement https://t.co/LgggPgoOP5

[CNWBiotech @CNWBiotech]

Neovasc's Tiara Mitral Valve Replacement Technology Featured in Update Presentation at the #CRT 2019 Meeting https://t.co/ZAfvxBVeYe

[CNWBiotech @CNWBiotech]

Major investment in #genomicsresearch will improve the lives of Canadians @GenomeCanada #genomics #CanadaSupportsScience https://t.co/Sc2CXEQwQF

[CNWBiotech @CNWBiotech]

.@BirchBioMed is cleared to begin first-of-its-kind phase II clinical trial for ground-breaking anti-scarring drug https://t.co/XO9JDBN7rk #clinicaltrials #AntiScarring

[CNWBiotech @CNWBiotech]

Partners agree on initial funding to kick off waste-to-chemistry project in Rotterdam https://t.co/lYqcS9ZMQT @Enerkem #financing #Rotterdam

[CNWBiotech @CNWBiotech]

.@Enerkem raises its largest financing round of C$280 million in new capital https://t.co/SP0fiKNSoF #biofuel #investment

[CNWBiotech @CNWBiotech]

.@AvicannaInc Completes 2nd Equity Financing & Welcomes New Strategic Shareholder https://t.co/V8XOfi2adg #JLABSToronto

[CNWBiotech @CNWBiotech]

Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic #Collaboration https://t.co/KBy0utI5Jh #CCTG

[CNWBiotech @CNWBiotech]

Marapharm Ventures Inc. will upgrade to trade on the OTCQX Best Market https://t.co/17MZQKXNxi

[CNWBiotech @CNWBiotech]

Next phase of TowerWise program set to show path to deep building energy efficiency @AtmosphericFund https://t.co/bJxhsyhzJA